Sociodemographic, clinical and survival profile of adult metastatic patients

Author:

Estumano Vanessa Kelly Cardoso1ORCID,Sagica Taís dos Passos2ORCID,Albuquerque Gisela Pereira Xavier3ORCID,Costa Marta Solange Camarinha Ramos3ORCID,Pereira Odenilce Vieira3ORCID,Melo Edjane Marcia Linhares2ORCID,Silva Sílvio Éder Dias da1ORCID,Ramos Aline Maria Pereira Cruz1ORCID

Affiliation:

1. Universidade Federal do Pará, Brasil

2. Universidade do Estado do Pará, Brasil

3. Hospital Universitário João de Barros Barreto, Brasil

Abstract

ABSTRACT Objective: To characterize the sociodemographic, clinical and survival profile of adult metastatic patients. Method: Retrospective cross-sectional study, with secondary data from an oncology care unit, analyzed using logistic regression, Chi-Square test and Fisher’s exact test, Kaplan-Meier and Log-Rank tests. Results: From the 678 patients, male gender, mean age 59.54 years old and low education level prevailed. The mean time between diagnosis and initiation of treatment was 89.50 days (± 58.87). Increased risk of primary cancer in the digestive tract (OR 1.42). Prevalence of adenocarcinoma (OR 1.53) and metastasis to bone (OR 2.59), lymph nodes (OR 1.75), liver and peritoneum (OR 1.42). The mean overall survival was 4.16 months and a median of 3.0 months. Conclusion: The main primary site was the digestive system, and the identification of metastases was predominantly unifocal liver in both genders. Overall patient survival was reduced by cancer progression.

Publisher

FapUNIFESP (SciELO)

Subject

General Nursing

Reference28 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung H;CA Cancer J Clin,2021

2. Interactions in the (pre)metastatic niche support metastasis formation;Doglioni G;Front Oncol,2019

3. Molecular principles of metastasis: a hallmark of cancer revisited;Fares J;Signal Transduct Target Ther,2020

4. Estimativas 2023: Incidência de Câncer no Brasil,2022

5. Clinical landscape of cancer metastases;Riihimäki M;Cancer Med,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3